Search results
Results from the WOW.Com Content Network
Baclofen, sold under the brand name Lioresal among others, is a medication used to treat muscle spasticity, such as from a spinal cord injury or multiple sclerosis. [8] [9] It may also be used for hiccups and muscle spasms near the end of life, [9] and off-label to treat alcohol use disorder [10] [11] or opioid withdrawal symptoms. [12]
In 2008, Ameisen wrote a best-selling book, The End Of My Addiction, published in France as Le Dernier Verre (The Last Glass), describing his experience of curing his alcoholism with baclofen. [6] In 2007, an Italian team also showed the effectiveness and the safety of baclofen as a treatment for alcohol addiction. [7]
This is usually placed in the left abdomen. It is a pump that is connected to the spinal cord, whereby it releases doses of baclofen to alleviate continuous muscle flexion. Baclofen is a muscle relaxant and is often given by mouth to people to help counter the effects of spasticity, although this has the side effect of sedating the individual. [69]
Both dicyclomine and hyoscyamine are antispasmodic due to their anticholinergic action. [medical citation needed] Both of these drugs have side effects common to anticholinergics and can worsen gastroesophageal reflux disease (GERD). [2] Papaverine is an opium alkaloid used to treat visceral spasms, particularly those of the intestines. [3]
The topic of baclofen for alcoholism is also before the NICE in the UK for consideration of the issuing of guidelines based on best evidence. Restricting the article to only published double blind studies does not capture the state of play in baclofen research, nor the controversy which is evidenced by the conflicting comments on this Talk board.
Anthem Blue Cross Blue Shield announced it will walk back plans to cap coverage of anesthesia care after widespread backlash.
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
Guatemala said it is open to engaging in a "constructive and respectful dialogue" with the new administration of incoming U.S. President Donald Trump, though no agreement has been made on ...